Catadegbrutinib (BGB-16673)

Catadegbrutinib (BGB-16673) is an inhibitor of Bruton’s tyrosine kinase (Btk) and can be used in research for the treatment of autoimmune and inflammatory diseases.

Trivial name BTK-IN-29
Catalog Number E1993
CAS# 2736508-60-2
Size 1g
Supplier Page http://www.selleckchem.com/products/bgb-16673.html
Additional Information https://file.selleck.cn/downloads/struct/E1993-BGB-16673-chemical-structure.png